Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

ATM, THMS, and RRM1 protein expression in nasopharyngeal carcinomas treated with curative intent.

Ko JJ, Klimowicz AC, Jagdis A, Phan T, Laskin J, Lau HY, Siever JE, Petrillo SK, Thomson TA, Rose MS, Bebb G, Magliocco AM, Hao D.

Head Neck. 2016 Apr;38 Suppl 1:E384-91. doi: 10.1002/hed.24004. Epub 2015 Jun 29.

PMID:
25640951
2.

Loss of the Notch effector RBPJ promotes tumorigenesis.

Kulic I, Robertson G, Chang L, Baker JH, Lockwood WW, Mok W, Fuller M, Fournier M, Wong N, Chou V, Robinson MD, Chun HJ, Gilks B, Kempkes B, Thomson TA, Hirst M, Minchinton AI, Lam WL, Jones S, Marra M, Karsan A.

J Exp Med. 2015 Jan 12;212(1):37-52. doi: 10.1084/jem.20121192. Epub 2014 Dec 15.

3.

Evaluation of E-cadherin, β-catenin and vimentin protein expression using quantitative immunohistochemistry in nasopharyngeal carcinoma patients.

Hao D, Phan T, Jagdis A, Siever JE, Klimowicz AC, Laskin JJ, Thomson TA, Rose MS, Petrillo SK, Magliocco AM, Lau HY.

Clin Invest Med. 2014 Oct 4;37(5):E320-30.

PMID:
25282138
4.

Assessment of ERCC1 and XPF protein expression using quantitative immunohistochemistry in nasopharyngeal carcinoma patients undergoing curative intent treatment.

Jagdis A, Phan T, Klimowicz AC, Laskin JJ, Lau HY, Petrillo SK, Siever JE, Thomson TA, Magliocco AM, Hao D.

Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1340-5. doi: 10.1016/j.ijrobp.2012.09.032. Epub 2012 Nov 22.

PMID:
23182703
5.

Haemophilia B: impact on patients and economic burden of disease.

Gater A, Thomson TA, Strandberg-Larsen M.

Thromb Haemost. 2011 Sep;106(3):398-404. doi: 10.1160/TH11-03-0193. Epub 2011 Aug 11. Review.

PMID:
21833450
6.

Fine-needle aspiration of renal and extrarenal rhabdoid tumors: the experience of the Institut Curie regarding 20 tumors in 13 patients.

Thomson TA, Klijanienko J, Couturier J, Brisse H, Pierron G, Freneaux P, Sastre-Garau X, Lagace R, Bourdeaut F.

Cancer Cytopathol. 2011 Feb 25;119(1):49-57. doi: 10.1002/cncy.20121. Epub 2010 Nov 8.

7.

Tissue microarray for routine clinical breast biomarker analysis. The British Columbia Cancer Agency 2008 experience.

Thomson TA, Zhou C, Ceballos K, Knight B.

Am J Clin Pathol. 2010 Jun;133(6):909-14. doi: 10.1309/AJCP1IU7BTSAQGYZ.

PMID:
20472849
8.

Tissue microarray for routine analysis of breast biomarkers in the clinical laboratory.

Thomson TA, Zhou C, Chu C, Knight B.

Am J Clin Pathol. 2009 Dec;132(6):899-905. doi: 10.1309/AJCPW37QGECDYCDO.

PMID:
19926582
9.

Clinical impact of second pathology opinion: a longitudinal study of central genitourinary pathology review before prostate brachytherapy.

Thomas CW, Bainbridge TC, Thomson TA, McGahan CE, Morris WJ.

Brachytherapy. 2007 Apr-Jun;6(2):135-41.

PMID:
17434107
10.

In vitro and in Vivo inhibition of immunoglobulin secretion by the immunosuppressive compound HR325 is reversed by exogenous uridine.

Thomson TA, Spinella-Jaegle S, Francesconi E, Meakin C, Millet S, Flao KL, Hidden H, Ruuth E.

Scand J Immunol. 2002 Jul;56(1):35-42.

11.

HER-2/neu in breast cancer: interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization.

Thomson TA, Hayes MM, Spinelli JJ, Hilland E, Sawrenko C, Phillips D, Dupuis B, Parker RL.

Mod Pathol. 2001 Nov;14(11):1079-86.

12.

Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: a well-tolerated therapy for established solid tumors.

Djeha AH, Thomson TA, Leung H, Searle PF, Young LS, Kerr DJ, Harris PA, Mountain A, Wrighton CJ.

Mol Ther. 2001 Feb;3(2):233-40.

13.

Inhibition of stimulated Jurkat cell adenosine 3',5'-cyclic monophosphate synthesis by the immunomodulatory compound HR325.

Curnock AP, Thomson TA, Westwood R, Kuo EA, Williamson RA, Yea CM, Ruuthb E.

Biochem Pharmacol. 2001 Jan 15;61(2):227-35.

PMID:
11163337
14.

Unique cytologic and chromosome aberrations in chondroid lipoma.

Thomson TA, Bainbridge TC, Horsman D.

Am J Surg Pathol. 2000 Jul;24(7):1035. No abstract available.

PMID:
10895830
15.

The comet assay in clinical practice.

Olive PL, Durand RE, Jackson SM, Le Riche JC, Luo C, Ma R, McLaren DB, Aquino-Parsons C, Thomson TA, Trotter T.

Acta Oncol. 1999;38(7):839-44.

PMID:
10606413
16.

Cytogenetic and cytologic features of chondroid lipoma of soft tissue.

Thomson TA, Horsman D, Bainbridge TC.

Mod Pathol. 1999 Jan;12(1):88-91.

PMID:
9950168
17.

Small cell carcinoma of the uterine cervix: cytologic findings in 13 cases.

Zhou C, Hayes MM, Clement PB, Thomson TA.

Cancer. 1998 Oct 25;84(5):281-8.

PMID:
9801202
18.

Potencies of leflunomide and HR325 as inhibitors of prostaglandin endoperoxide H synthase-1 and -2: comparison with nonsteroidal anti-inflammatory drugs.

Curnock AP, Robson PA, Yea CM, Moss D, Gadher S, Thomson TA, Westwood R, Ruuth E, Williamson RA.

J Pharmacol Exp Ther. 1997 Jul;282(1):339-47.

PMID:
9223572
19.

Dihydroorotate dehydrogenase is a high affinity binding protein for A77 1726 and mediator of a range of biological effects of the immunomodulatory compound.

Williamson RA, Yea CM, Robson PA, Curnock AP, Gadher S, Hambleton AB, Woodward K, Bruneau JM, Hambleton P, Moss D, Thomson TA, Spinella-Jaegle S, Morand P, Courtin O, Sautés C, Westwood R, Hercend T, Kuo EA, Ruuth E.

J Biol Chem. 1995 Sep 22;270(38):22467-72.

20.

Inhibition of interleukin 1 beta induced rat and human cartilage degradation in vitro by the metalloproteinase inhibitor U27391.

Seed MP, Ismaiel S, Cheung CY, Thomson TA, Gardner CR, Atkins RM, Elson CJ.

Ann Rheum Dis. 1993 Jan;52(1):37-43.

21.
22.

Differential interactions of Ro 15-4513 with benzodiazepines, ethanol and pentobarbital.

Deacon RM, Budhram P, Thomson TA, Gardner CR.

Eur J Pharmacol. 1990 May 16;180(2-3):283-90.

PMID:
1973116
23.

In vitro release of arachidonic acid and in vivo responses to respirable fractions of cotton dust.

Thomson TA, Edwards JH, Al-Zubaidy TS, Brown RC, Poole A, Nicholls PJ.

Environ Health Perspect. 1986 Apr;66:87-90.

24.

Herpesvirus type 1 serum antibodies and brain tumors in humans.

Hadfield MG, Murray BK, Thomson TA, Young HF.

Clin Neuropathol. 1984 Mar-Apr;3(2):68-71.

PMID:
6325061
25.
26.

Immune responses to labial infection of BALB/c mice with herpes simplex virus type 1.

Morahan PS, Thomson TA, Kohl S, Murray BK.

Infect Immun. 1981 Apr;32(1):180-7.

27.

Molecular similarities among the adenovirus-associated virus polypeptides and evidence for a precursor protein.

Johnson FB, Thomson TA, Taylor PA, Vlazny DA.

Virology. 1977 Oct 1;82(1):1-13. No abstract available.

PMID:
898671
28.

Medical students in community physicians' offices.

Livingston MC, Thomson TA, Vaughan GA, Bass S, Lee HP, Malpass PB, Wong WT, Youngash RN, Zack PS.

Can Med Assoc J. 1974 Nov 2;111(9):969-71.

29.

Six medical students in a community hospital.

Livingston MC, Bass S, Emery AW, Thomson TA, Vaughan GA, Wong WT, Youngash RN, Zack PS.

Can Med Assoc J. 1973 Nov 17;109(10):1013-6.

Supplemental Content

Loading ...
Support Center